Medicare Advantage Enrollees With Kidney Failure Had Lower Transplant Rates

A retrospective cohort study of over 630,000 Medicare beneficiaries with end-stage kidney disease compared transplant and wait-listing rates between Medicare Advantage and traditional Medicare in the first three years after the 21st Century Cures Act expanded Medicare Advantage eligibility to this population. The study reported that Medicare Advantage beneficiaries had lower adjusted rates of kidney transplant, new wait-listing, and transplant among those already wait-listed, with differences stable across 2021-2023 and widest among beneficiaries aged 18-44. The authors state that policy oversight may be needed to monitor access to transplant in the growing Medicare Advantage population.

Most relevant for: Patients with end-stage kidney disease enrolled in Medicare Advantage, particularly younger adults being evaluated for kidney transplant or wait-list placement.

Summary written by an AI model from the source text and dated by the source's publication date. Check the original before acting on it. How MedFollow selects and summarizes updates.

Informational only. Not medical advice. Not a substitute for clinical judgment. Always consult current guidelines and your own clinical judgment.